Effects of Shexiangbaoxin pills on the expression of cardiac α1- and β-adrenergic receptor subtypes in rat hearts with heart failure induced by myocardial infarction

Chinese Medical Journal

Volumn 125, Issue 9, 2012, Pages 1556-1562

  Li, Yan Fang ^a   Cao, Fang Fang ^b   Liu, Fei ^a   Bai, Xue Yuan ^c   Lü, Yang ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b FUWAI HOSPITAL   (China)

^c Department of Nephrology   (China)

Author keywords

Adrenergic receptor; Heart failure; Myocardial infarction; Rat

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CHINESE DRUG; ISOSORBIDE DINITRATE; SHEXIANGBAOXIN PILL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DRUGS, CHINESE HERBAL; ECHOCARDIOGRAPHY; HEART FAILURE; MALE; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84863208973     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.09.007     Document Type: Article

References (18)

1. Lymperopoulos A, Rengo G, Koch WJ. Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation. Trends Mol Med 2007; 13: 503-511.
2. Wang S, Zheng Z, Weng Y, Yu Y, Zhang D, Fan W, et al. Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sci 2004; 74: 2467-2478.
3. Tsuneyoshi H, Oriyanhan W, Kanemitsu H, Shiina R, Nishina T, Ikeda T, et al. Heterotopic transplantation of the failing rat heart as a model of left ventricular mechanical unloading toward recovery. ASAIO J 2005; 51: 116-120.
4. Wang J, Tsukashita M, Nishina T, Marui A, Yoshikawa E, Muranaka H, et al. Chronic partial unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in failing rat hearts. J Thorac Cardiovasc Surg 2009; 137: 465-470.
5. El-Armouche A, Eschenhagen T. Beta-adrenergic stimulation and myocardial function in the failing heart. Heart Fail Rev 2009; 14: 225-241.
6. Ahmet I, Morrell C, Lakatta EG, Talan MI. Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of post-MI dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor. J Pharmacol Exp Ther 2009; 331: 178-185.
7. Rasmussen HH, Figtree GA, Krum H, Bundgaard H. The use of beta3-adrenergic receptor agonists in the treatment of heart failure. Curr Opin Investig Drugs 2009; 10: 955-962.
8. Gan RT, Li WM, Xiu CH, Shen JX, Wang X, Wu S, et al. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure. Chin Med J 2007; 120: 2250-2255.
9. Xu KM, Zhang YY, Qu P. Alteration of alpha1 subtypes in cardiac insufficiency rats. Med J Chin Acta Physiol Sinica 1996; 48: 437-442.
10. O'Connell TD, Ishizaka S, Nakamura A, Swogart PM, Rodrigo MC, Simpson GL, et al. The alpha (1A/C)-and alpha (1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J Clin Invest 2003; 111: 1783-1791.
11. Mccloskey DT, Rokosh DG, O'Connell TD, Keung EC, Simpson PC, Baker AJ. Alpha(1)-adrenoceptor subtypes mediate negative inotropy in myocardium from alpha(1A/C)-knockout and wild type mice. J Mol Cell Cardiol 2002; 34: 1007-1017.
12. McCloskey DT, Turnbull L, Swigart P, O'Connell TD, Simpson PC, Baker AJ. Abnormal myocardial contraction in alpha(1A)-and alpha(1B)-adrenoceptor double-knockout mice. J Mol Cell Cardiol 2003; 35: 1207-1216.
13. Du XJ, Gao XM, Kiriazis H, Moore XL, Ming Z, Su Y, et al. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival. Cardiovasc Res 2006; 71: 735-743.
14. Woodcock EA, Du XJ, Reichelt ME, Graham RM. Cardiac alpha1-adrenergic drive in pathological remodelling. Cardiovasc Res 2008; 77: 452-462.
15. Wang BH, Du XJ, Autelitano DJ, Milano CA, Woodcock EA. Adverse effects of constitutively active alpha(1B)-adrenergic receptors after pressure overload in mouse hearts. Am J Physiol Heart Circ Physiol 2000; 279: H1079-H1086.
16. Turnbull L, McCloskey DT, O'Connell TD, Simpson PC, Baker AJ. Alpha 1-adrenergic receptor responses in alpha 1AB-AR knockout mouse hearts suggest the presence of alpha 1D-AR. Am J Physiol Heart Circ Physiol 2003; 284: H1104-H1109.
17. Tanoue A, Nasa Y, Koshimizu T, Shinoura H, Oshikawa S, Kawai T, et al. The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Invest 2002; 109: 765-775.
18. Brattelid T, Tveit K, Birkeland JA, Sjaastad I, Qvigstad E, Krobert KA, et al. Expression of mRNA encoding G protein-coupled receptors involved in congestive heart failure-a quantitative RT-PCR study and the question of normalization. Basic Res Cardiol 2007; 102: 198-208.